Anatara e-news 25/06/15
View this email in your browser

G7 vows to combat antibiotic resistance

At the G7 summit in Germany earlier this month, world leaders vowed to invest in research aimed at halting the rise of antibiotic-resistant illnesses, and supported the recently released World Health Organization (WHO) global action plan on antimicrobial resistance. Read More >>

Anatara presents at BIO2015

Last week, Anatara's Chief Scientific Officer, Dr Tracey Mynott, presented a company and technology overview in the "Gastrointestinal" session of the BIO Business Forum, as part of the BIO International Convention in Philadelphia.

Anatara in the news

Anatara received strong media coverage last week on the back of our two recent announcements regarding the second DetachTM field trial and our investor update.
  • "Pooey pigs could be a thing of the past" - Australian Life Scientist
  • "Anatara Lifesciences Commences Second Detach Trial" - Biospace
  • "ANATARA LIFESCIENCES" - Biotech Daily 18/06/15
  • "Fee waiver speeds pig diarrhea treatment path to US" -  Animal Pharm
  • "Anatara (ANR) 90c" - Criterion, Tim Boreham, The Australian (see below)

Dr Tracey Mynott on stage at the BIO2015 Business Forum 
Bioshares Biotech Summit (Queenstown, NZ)
17-18 July 2015

The summit will provide an opportunity to showcase Anatara to existing and potential
fund managers and retail investors.  

Don't forget to find us on Twitter...

Follow us @AnataraANR

Copyright © 2015 Anatara Lifesciences Ltd, All rights reserved.

unsubscribe from this list    update subscription preferences